Skip to main content

Closed

NSRX: Nasus Pharma Ltd. Financial Statements & Revenue | finqOS

Healthcare · Medical - Pharmaceuticals

52W Range

13thpctl

Volume

0.15×avg

Market Cap

26.10MUSD

P/E Ratio

-17.8TTM

Div Yield

-ann

Nasus Pharma Ltd.

NSRXNew York Stock Exchange Arca·USD·Closed

Nasus Pharma Ltd.

NSRXNew York Stock Exchange Arca·USD·Closed

$3.03

−4.72%

$3.03

−$0.15 (4.72%)

52W Range

13thpctl

Volume

0.15×avg

Mkt Cap

26.10MUSD

P/E

-17.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings